Steven Cohen started to build up the position in CRISPR Therapeutics AG in Q1 2019 and continued to invest until Q2 2019. Since then they sold 7.06 Thousand shares. The investor completely sold their stake between Q3 2019 and Q4 2019.
Avg closing price
Price range
Sold -6.46 Thousand shares
Q4 2019
Avg closing price
$54.60
Price range
$36.68
-
$73.13
Sold 8.5% shares (-600 shares)
Q3 2019
Avg closing price
$47.78
Price range
$40.99
-
$52.56
Increased shares by 55.9% (+2.53 Thousand shares)
Q2 2019